Prutis (Nintedanib) Soft Gelatin Capsules are antifibrotic medicines used in the treatment of Idiopathic Pulmonary Fibrosis (IPF), Interstitial Lung Disease (ILD), and Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD). Available in 100 mg and 150 mg strengths, Nintedanib helps slow the progression of lung fibrosis by inhibiting pathways involved in scar tissue formation within the lungs. This therapy may help preserve lung function and improve disease management when used as prescribed. Common side effects can include diarrhea, nausea, abdominal discomfort, and elevated liver enzymes. Patients should follow medical advice regarding dosage, monitoring, precautions, and potential drug interactions during treatment.